Biotechnology R&D intensity in enterprise sector by country 2017

This statistic shows the research and development intensity of biotechnology companies in selected countries for 2017 (or latest year available - 2015, 2016). As of that year, U.S. biotech R&D in the enterprise sector was around 0.38 percent of the total industry value added.

Biotech R&D intensity in the enterprise sector in selected countries as of 2017

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

October 2018


Worldwide, OECD

Survey time period

2015 to 2017

Supplementary notes

* Or latest year available (2015, 2016).
For the Russian Federation, a proxy indicator is used: R&D expenditure in Life Sciences (before 2011 - Living Systems), which include bioengineering, biocatalysis, biosynthesis and biosensor technologies, biomedical and veterinary technologies, genomics and pharmaco-genetics, living cell technologies.
For Sweden, firms with 10 or more employees only.
For the United States, firms with 5 or more employees only.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.